Table 4 Prognostic features (PFS) in young patients (≤50 years), Cox regression analyses
From: Are there candidates for high-dose chemotherapy in ovarian carcinoma?
Univariate analysis | Multivariate analysis | |||||||
|---|---|---|---|---|---|---|---|---|
N | HR | 95CI | p-value | N | HR | 95CI | p-value | |
OMS (0-1 vs 2-3) | 36 | 1.76 | 0.71-4.38 | 0.22 | ||||
FIGO (IIIc vs IV) | 52 | 0.57 | 0.25-1.33 | 0.19 | ||||
Histology (serous vs others) | 52 | 0.81 | 0.51-1.56 | 0.52 | ||||
Grade (1-2 vs 3) | 31 | 1.31 | 0.83-2.08 | 0.25 | ||||
Serous grade 3 (vs others) | 31 | 1.06 | 0.59-1.88 | 0.85 | ||||
Surgery (complete vs non complete) | 52 | 0.29 | 0.15-.058 | 4.97 E-07 | 51 | 0.43 | 0.19-0.94 | 0.034 |
Complete clinical remission (Yes vs No) | 51 | 0.22 | 0.11-0.45 | 3.65 E-05 | 51 | 0.33 | 0.15-0.74 | 0.007 |
CA-125 (normal vs >normal) | 44 | 1.87 | 0.84-4.16 | 0.12 | ||||
Treatment (CCA vs HDC) | 52 | 2.44 | 1.14-5.25 | 0.02 | 51 | 2.31 | 1.06-5.04 | 0.036 |